Project documents | Axitinib, everolimus, sorafenib and sunitinib for treated advanced or metastatic renal cell carcinoma [ID897] | Guidance | NICE

Documents

Documents created during the development process.

Invitation to participate

Final protocol (MSWord 97 KB)

Published:

09 February 2016

Invitation to participate

Final scope (PDF 119 KB)

Published:

19 January 2016
Final matrix (PDF 101 KB)

Published:

19 January 2016
NICE's response to comments on the draft scope and provisional matrix (PDF 257 KB)

Published:

19 January 2016
Equality Impact Assessment (Guidance development) (MSWord 37 KB)

Published:

21 January 2016

Draft scope

Draft scope
Draft scope (PDF 129 KB)

Published:

06 October 2015

Provisional matrix

Provisional matrix
Provisional matrix (PDF 103 KB)

Published:

06 October 2015